Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

COVID-19 NanoAb - Scinai Immunotherapeutics/ The Max Planck Society/ University Medical Center Gottingen

Next Previous
Drug Profile

COVID-19 NanoAb - Scinai Immunotherapeutics/ The Max Planck Society/ University Medical Center Gottingen

Alternative Names: COVID-19 NanoAb - Scinai Immunotherapeutics/The Max Planck Society/University Medical Center Gottingen; COVID-19 nanobodies - Scinai Immunotherapeutics/The Max Planck Society/University Medical Center Gottingen; COVID-19 nanosized antibodies - Scinai Immunotherapeutics/The Max Planck Society/University Medical Center Gottingen; COVID-19 VHH antibodies - Scinai Immunotherapeutics/The Max Planck Society/University Medical Center Gottingen

Latest Information Update: 11 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator The Max Planck Society; University Medical Center Gottingen
  • Developer Scinai Immunotherapeutics; The Max Planck Society; University Medical Center Gottingen
  • Class Antivirals; Single-domain antibodies
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical COVID 2019 infections

Most Recent Events

  • 06 Sep 2023 BiondVax Pharmaceuticals is now called Scinai Immunotherapeutics
  • 11 Aug 2023 COVID-19 NanoAb - BiondVax Pharmaceuticals/ The Max Planck Society/ University Medical Center Gottingen is available for licensing as of 11 Aug 2023. https://www.biondvax.com/nanoabs
  • 15 May 2023 Pharmacodynamics data from a preclinical trial in COVID-2019 infections released by BiondVax Pharmaceuticals

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top